Shuji Kubo

2.3k citations

68 papers · 1.8k indexed · h-index 22

Developmental Neuroscience top 1%
- Neurogenesis and neuroplasticity mechanisms 8
Neurology top 2%
Genetics top 5%
- Virus-based gene therapy research 23
- Mesenchymal stem cell research 6
Clinical Biochemistry top 5%
Molecular Biology top 10%
- RNA Interference and Gene Delivery 8
- Viral Infectious Diseases and Gene Expression in Insects 6
Oncology
- CAR-T cell therapy research 9
Biotechnology
- Cancer Research and Treatments 8
Immunology
- Immunotherapy and Immune Responses 7

Co-authors: Takayuki Nakagomi Akiko Nakano‐Doi Tomohiro Matsuyama Akihiko Taguchi Takashi Kuwahara S. Asanami Noriyuki Kasahara Nami Nakagomi
Cited by: Developmental Neuroscience Neurology Genetics
Journals: Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (1 paper)The Journal of Immunology (1 paper)
Partner nations: Japan United States Netherlands

In The Last Decade

Shuji Kubo

67 papers receiving 1.8k citations

Peers

Countries citing papers authored by Shuji Kubo

Since Specialization

Citations

This map shows the geographic impact of Shuji Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Kubo more than expected).

Fields of papers citing papers by Shuji Kubo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Kubo. The network helps show where Shuji Kubo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shuji Kubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuji Kubo Line = papers co-authored together Shuji Kubo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke Cells ·Shuichi Fujiwara,Akiko Nakano‐Doi,Toshinori Sawano,Shuji Kubo,Nobutaka Doe,Takayuki Nakagomi	2024	5
2	Human-Brain-Derived Ischemia-Induced Stem Cell Transplantation Is Associated with a Greater Neurological Functional Improvement Compared with Human-Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Mice After Stroke International Journal of Molecular Sciences ·Shuichi Tanada,Takayuki Nakagomi,Akiko Nakano‐Doi,Toshinori Sawano,Shuji Kubo,Yoji Kuramoto,Kazutaka Uchida,Kenichi Yamahara,Nobutaka Doe,(unknown)	2024	2
3	Transplantation of Human Brain-Derived Ischemia-Induced Multipotent Stem Cells Ameliorates Neurological Dysfunction in Mice After Stroke Stem Cells Translational Medicine ·Takayuki Nakagomi,Akiko Nakano‐Doi,Shuji Kubo,Toshinori Sawano,Yoji Kuramoto,Kenichi Yamahara,Tomohiro Matsuyama,Toshinori Takagi,Nobutaka Doe,Shinichi Yoshimura	2023	12
4	Different Contacted Cell Types Contribute to Acquiring Different Properties in Brain Microglial Cells upon Intercellular Interaction International Journal of Molecular Sciences ·Akiko Nakano‐Doi,Shuji Kubo,Emiko Sonoda,Akihiko Taguchi,Takayuki Nakagomi	2023	5
5	Microglia Negatively Regulate the Proliferation and Neuronal Differentiation of Neural Stem/Progenitor Cells Isolated from Poststroke Mouse Brains Cells ·Yoshinobu Hirano,Takayuki Nakagomi,Akiko Nakano‐Doi,Shuji Kubo,Yusuke Minato,Toshinori Sawano,Masafumi Sakagami,Kenzo Tsuzuki	2023	4
6	Assessment of circulating microRNA specific for patients with familial adenomatous polyposis PLoS ONE ·Tomoki Yamano,Shuji Kubo,Emiko Sonoda,Tomoko Kominato,Kei Kimura,Michiko Yasuhara,Kozo Kataoka,J. Son,Akihito Babaya,Yuya Takenaka,Takaaki Matsubara,Naohito Beppu,Masataka Ikeda	2021	8
7	Dual-vector prodrug activator gene therapy using retroviral replicating vectors Cancer Gene Therapy ·Shuji Kubo,Misato Takagi‐Kimura,Masatoshi Tagawa,Noriyuki Kasahara	2018	17
8	Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors Cancer Gene Therapy ·Shuji Kubo,Misato Takagi‐Kimura,Noriyuki Kasahara	2018	10
9	Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma APOPTOSIS ·Suguru Yamauchi,Kiyoko Kawamura,Shinya Okamoto,Takao Morinaga,Yuanyuan Jiang,Masato Shingyoji,Ikuo Sekine,Shuji Kubo,Yuji Tada,Koichiro Tatsumi,Hideaki Shimada,Kenzo Hiroshima,Masatoshi Tagawa	2015	4
10	Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells Cancer Gene Therapy ·Yoshio Takei,Shinya Okamoto,K Kawamura,Yuanyuan Jiang,Takao Morinaga,Masato Shingyoji,Ikuo Sekine,Shuji Kubo,Yuji Tada,Koichiro Tatsumi,Hideaki Shimada,Kenzo Hiroshima,Naoto Yamaguchi,Masatoshi Tagawa	2015	6
11	FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway Cellular Signalling ·Ryoji Eguchi,Shuji Kubo,Toshiro Ohta,Kazuhiro Kunimasa,Masaya Okada,Hiroya Tamaki,Kazuhiko Kaji,Ichiro Wakabayashi,Yoshihiro Fujimori,Hiroyasu Ogawa	2013	12
12	Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells Carcinogenesis ·Ryoji Eguchi,Shuji Kubo,H Takeda,Toshiro Ohta,Chiharu Tabata,Hiroyasu Ogawa,Takashi Nakano,Yoshihiro Fujimori	2012	19
13	Ischemia-Induced Neural Stem/Progenitor Cells in the Pia Mater Following Cortical Infarction Stem Cells and Development ·Takayuki Nakagomi,Zoltán Molnár,Akiko Nakano‐Doi,Akihiko Taguchi,Orie Saino,Shuji Kubo,Martijn Clausen,Hiroo Yoshikawa,Nami Nakagomi,Tomohiro Matsuyama	2011	109
14	Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma Cancer Gene Therapy ·Yoshiaki Kawasaki,Atsuko Tamamoto,Misato Takagi‐Kimura,Yoshihiro Maeyama,Norie Yamaoka,Nobuyuki Terada,Haruki Okamura,Noriyuki Kasahara,Shuji Kubo	2011	18
15	Adenovirus–Retrovirus Hybrid Vectors Achieve Highly Enhanced Tumor Transduction and Antitumor Efficacy In Vivo Molecular Therapy ·Shuji Kubo,Kazunori Haga,Atsuko Tamamoto,Donna Palmer,Philip Ng,Haruki Okamura,Noriyuki Kasahara	2010	11
16	Effect of IL-18 on Expansion of γδ T Cells Stimulated by Zoledronate and IL-2 Journal of Immunotherapy ·Wen Li,Shuji Kubo,A Okuda,Hideyuki Yamamoto,Haruyasu Ueda,Toshiyuki Tanaka,Hideji Nakamura,Hiromichi Yamanishi,Nobuyuki Terada,Haruki Okamura	2010	49
17	Isolation and characterization of neural stem/progenitor cells from post‐stroke cerebral cortex in mice European Journal of Neuroscience ·Takayuki Nakagomi,Akihiko Taguchi,Yoshihiro Fujimori,Orie Saino,Akiko Nakano‐Doi,Shuji Kubo,Akinobu Gotoh,Toshihiro Soma,Hiroo Yoshikawa,Tomoyuki Nishizaki,Nami Nakagomi,David M. Stern,Tomohiro Matsuyama	2009	87
18	SANGYO EISEIGAKU ZASSHI ·Yoshikazu Takahashi,Kazumi Matsuki,Shuji Kubo,Jun Muramatsu	2004	1
19	Adenovirus As An Integrating Vector Current Gene Therapy ·K Mitani,Shuji Kubo	2002	66
20	A neonatal case of hydranencephaly caused by atheromatous plaque obstruction of aortic arch: possible association with a congenital cytomegalovirus infection? PubMed ·Shuji Kubo,Tomonori Kishino,Noriko Satake,M. Okano,Makoto Mikawa,Norihiro Ishikawa	1994	9

About Shuji Kubo

Shuji Kubo is a scholar working on Developmental Neuroscience, Neurology and Biotechnology, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), CAR-T cell therapy research (9 papers), RNA Interference and Gene Delivery (8 papers), Cancer Research and Treatments (8 papers), Neurogenesis and neuroplasticity mechanisms (8 papers), Immunotherapy and Immune Responses (7 papers), Mesenchymal stem cell research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). The work is most often cited by research in Developmental Neuroscience (337 citations), Neurology (332 citations) and Genetics (256 citations). Shuji Kubo has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Takayuki Nakagomi, Akiko Nakano‐Doi, Tomohiro Matsuyama, Akihiko Taguchi, Takashi Kuwahara, S. Asanami, Noriyuki Kasahara, Nami Nakagomi, Hiroo Yoshikawa and K Mitani. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact